病毒性肝炎患者血清镁的含量及意义

检测４６例病毒性肝炎患者血清镁含量，并观察了患者的血清镁与ＡＬＴ、ＡＦＰ变化的关系。结果：慢活型病毒性肝炎组的病人血清镁含量降低，与正常人群比较有差异（Ｐ＜０．０５）；肝炎后肝硬化、慢重型病毒性肝炎组的病人血清镁含量明显降低，与正常人群比较有显著性差异（Ｐ＜０．０１）。患者ＡＬＴ、ＡＦＰ升高时血清镁含量显著降低（Ｐ＜０．０１），当患者的ＡＬＴ、ＡＦＰ恢复正常时，血清镁含量上升（Ｐ＞０．０５）。结果表明：病毒性肝炎患者血清镁含量的高低可视为判断病情轻重，肝功能损伤的程度，同时也提供了慢活型、慢重型病毒性肝炎、肝炎后肝硬化的病人治疗时应注意补充镁盐。

SERUM MAGNESIUM LEVEL AND CLINICAL SIGNIFICANCE IN PATIENTS WITH VIRAL HEPATITIS

The serum magnesium levels were determined in 46 cases of viralhepatitis end the relations between serum magnesium level and ALT or AFP wereobserved.The results were as follows:(1)the serum magnesium level in patients withchronic active hepatitis (CAH) was decreased and significantly different from that ofnormal persons(P<0.05);the serum magnesium level in posthepatitic cirrhosis andchronic fatal hepatitis(CFH) were abviously decreased and notably different from thatof normal persons(P<0.0.(2)the serum magnesium level was notably decreased asALT or AFP was increased(P<0.01);the serum magnesium was increased as ALT orAFP reached to normal level (P>0.05).These results reveal that the serum magnesiumIevel can be used to judge whether the conditions of patients and the damage to theIiver function are serious or not,and suggest that sttention should be paid to the supplyof magnesian salt in the treatment of CAH,CFH and posthepatitic cirrhosis.